The DOI matches its Crossref record.
A Multicenter Study Involving the Use of a Human Acellular Dermal Regenerative Tissue Matrix for the Treatment of Diabetic Lower Extremity Wounds
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pooled average time to heal for ADM group is around 2e7 weeks shorter than that reported by previous retrospective studies [22,25].”
From Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis (2017) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 6
- Brigido, 2004, Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study., Orthopedics, 27, s145, 10.3928/0147-7447-20040102-14 · DOI · Paper page
- Martin, 2005, Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience., Int Wound J, 2, 161, 10.1111/j.1742-4801.2005.00099.x · DOI · Paper page
- Armstrong, 1998, Who is at risk for diabetic foot ulceration?, Clin Podiatr Med Surg, 15, 11, 10.1016/S0891-8422(23)01025-X · DOI
- Lavery, 1996, Classification of diabetic foot ulcerations., J Foot Ankle Surg, 35, 528, 10.1016/S1067-2516(96)80125-6 · DOI
- Veves, 2001, Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers., Diabetes Care, 24, 290, 10.2337/diacare.24.2.290 · DOI · Paper page
- Veves, 2002, A randomized, controlled trial of Promogran versus standard treatment in the management of diabetic foot ulcers., Arch Surg, 137, 822, 10.1001/archsurg.137.7.822 · DOI
Cited by
Guo, X., Mu, D., & Gao, F. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.02.008 · Cited by 80
Cazzell, S., Vayser, D., Pham, H., Walters, J., Reyzelman, A., Samsell, B., Dorsch, K., & Moore, M. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12551 · Cited by 78
Metadata
- Authors
- Winters, C. L., Brigido, S. A., Liden, B. A., Simmons, M., Hartman, J. F., & Wright, M. L.
- Venue
- Advances in Skin & Wound Care
- Published
- 2008-08
- Volume
- 21
- Issue
- 8
- Pages
- 375-381
- ISSN
- 1527-7941
- Cited by
- 58
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.